Why the study?
Does minimally invasive direct coronary artery bypass (MIDCAB) reduce systemic inflammation compared to conventional CABG with cardiopulmonary bypass in patients undergoing coronary revascularization?
Population
57 patients undergoing coronary artery bypass grafting (CABG)
Comparison
Minimally invasive direct coronary artery bypass… vs Conventional coronary artery bypass grafting…
Design
Cohort
Follow-up
42 hours
Authors
Loading...
MIDCAB may attenuate postoperative inflammation; this Level 3 cohort finding leaves open outcome benefits versus conventional CABG.
Does minimally invasive direct coronary artery bypass (MIDCAB) reduce systemic inflammation compared to conventional CABG with cardiopulmonary bypass in patients undergoing coronary revascularization?
Minimally invasive direct coronary artery bypass (MIDCAB) without cardiopulmonary bypass induces a significantly lower systemic inflammatory response, as measured by procalcitonin levels, compared to conventional CABG.
Kilger et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: